Apoptosis, proliferation and inflammation are improved after treatment with the new selective glp-2 receptor agonist, elsiglutide, in a rat model of irinotecan-induced mucositis

Bronwen Mayo,Andrea M. Stringer,Emma Bateman,Joanne M. Bowen,Anthony Wignall,Belinda Wozniak,I. White,C. Pietra,S. Cantoreggi,Dorothy Keefe

Apoptosis, proliferation and inflammation are improved after treatment with the new selective glp-2 receptor agonist, elsiglutide, in a rat model of irinotecan-induced mucositis

2014

Bronwen Mayo
Andrea M. Stringer
Emma Bateman
Joanne M. Bowen
Anthony Wignall
Belinda Wozniak
I. White
C. Pietra
S. Cantoreggi
Dorothy Keefe

Bronwen Mayo, Andrea Stringer, Emma Bateman, Joanne Bowen, Anthony Wignall, Belinda Wozniak, Imogen White, Claudio Pietra, Sergio Cantoreggi, Dorothy Keefe

Keywords:

Agonist
Inflammation
Apoptosis
Pharmacology
Receptor
Irinotecan
Medicine
ELSIGLUTIDE
Mucositis
after treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations